- Home
- SYRE vs DAVE Comparison
SYRE vs DAVE Comparison
Compare SYRE & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | DAVE |
|---|---|---|
| Founded | 2013 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | SYRE | DAVE |
|---|---|---|
| Price | $33.03 | $227.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $56.50 | ★ $282.17 |
| AVG Volume (30 Days) | ★ 925.8K | 394.6K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 224.46 |
| EPS | N/A | ★ 10.12 |
| Revenue | N/A | ★ $491,301,000.00 |
| Revenue This Year | N/A | $56.88 |
| Revenue Next Year | N/A | $18.07 |
| P/E Ratio | ★ N/A | $21.84 |
| Revenue Growth | N/A | ★ 53.84 |
| 52 Week Low | $10.91 | $65.46 |
| 52 Week High | $35.31 | $286.45 |
Technical Indicators
Market Signals| Indicator | SYRE | DAVE |
|---|---|---|
| Relative Strength Index (RSI) | 62.10 | 61.42 |
| Support Level | $32.50 | $188.00 |
| Resistance Level | $34.84 | $226.00 |
| Average True Range (ATR) | 1.48 | 11.92 |
| MACD | -0.37 | 3.78 |
| Stochastic Oscillator | 25.90 | 96.88 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.